Auditor

@BiotechAnalysst $sgmo Grok on Fabry 2yr data x.com/i/grok/share/6…

$SGMO Grok: So in short: This is the market getting a heads-up that Sangamo’s 2-year Fabry data is officially filed and a PR drop is imminent. Classic biotech catalyst watch.

$SGMO Fabry trial just updated 2 year data should now be available with data cutoff april 10, 2026 (last friday) tic toc ... PR #version-content-panel" target="_blank" rel="nofollow noopener">clinicaltrials.gov/study/NCT04046…

@BiotechAnalysst Are potential business partners for Fabry waiting for this dataset? $sgmo

@JimFergusonUK The 1.4 billion people claim by the CCP seems not realistic due to the one child policy enforced for several decades. Some experts are saying it is more like 600 million!

🚨 CHINA RESPONDS — “A WALL OF STEEL” President Xi Jinping issues a clear warning: China will not be intimidated. China will not be pressured. China will not back down. “Anyone who attempts to bully us will collide with a wall of steel forged by 1.4 billion people.” This isn’t diplomatic language— It’s a message. Strength. Resolve. Defiance. As tensions rise in the Gulf— The world’s second superpower is now speaking directly. Because when China steps in— The stakes don’t just rise. They change completely. Watch this closely.

@Orlando71156528 If Russia interferes, U.S. will send long range missiles and other advance weaponry to Ukraine! Likewise with China! Trump will do more with Taiwan and the Asian allies!

Rusia 🇷🇺 y China 🇨🇳, romperán el bloqueo de EEUU 🇺🇸 a la salida del estrecho de ormuz, escoltados por sus buques de guerra 🪖. ¿Y que podrá hacer trump? Absolutamente nada.

Looks like $beam has bottomed and came back into the parallel channel. Would like to see it to test the bottom channel around $28.50 for confirmation and so happened to be the previous support.

@Franca_ole $sgmo Grok simplifies this tech doc on Nav 1.7 and 1.8 x.com/i/grok/share/8…

$VRTX $SGMO The paper shows that the excitability of pain neurons is not determined by individual sodium channels, but rather by their interaction. Different combinations of these channels give rise to different types of neurons, each with its own response to stimuli. In some cases, strong synergistic effects occur, such that the effects of individual channels can reinforce or modify one another. These findings explain why therapies that target only a single channel are often ineffective. Instead, the results suggest that future treatment approaches must take multiple channel types into account simultaneously in order to influence pain more effectively. biorxiv.org/content/10.648…

@realgerhardtvdm Wishful thinking; not after what they have done to Hong Kong!

🚨🇨🇳 MASSIVE BREAKING NEWS, WESTERN MAINSTREAM MEDIA KEEPS HUSH HUSH: President Xi Jingping meets with Cheng Li-wun Chairwoman of Taiwan's next ruling party (KMT), in Beijing. It's happening, reunification between Taiwan province and China mainland, The U.S. and Japan are crying like we've never seen before!

$ions fiercepharma.com/marketing/fier…

The success of this Hem A drug hinges on a well thought out marketing strategy.

@ArtsStocks @investuniversal Salanersen for SMA uses $ions new NMA tech for splicing. Don't think Elsunersen uses splicing. $prax

@auditor112017 @investuniversal Don’t need siRNA, $ions currently dosing every six months and every year in SMA trial. $prax #neurology

BIOTECH: $PRAX surges on Phase 1/2 data showing 77% placebo-adjusted seizure reduction for elsunersen in SCN2A epilepsy, per GlobeNewswire. Rare disease catalysts like this can reprice small-cap biotechs overnight — watch $IONS as ASO platform partner.

@ArtsStocks @investuniversal Believe monthly dosing for elsunersen.

If $tak still wants $sgmo HD program, they need $sgmo Stac-BBB to deliver the drug into the CNS.

Perhaps, it is time for $tak to return the Huntington program back to $sgmo. Why is Takeda still holding onto $sgmo asset while they have been terminating CNS related agreements left and right. biopharmadive.com/news/fda-exped…

@investuniversal Look for EMBRAVE3 data read out for elsunersen in 2026.

@investuniversal Looks like $ions is going to get another potential large revenue stream similar to $biib spinraza royalties for SMA. $Ions gets tiered royalties in the low-20s percent range on worldwide net sales of elsunersen! $prax

@investuniversal Not sure if any of the analysts have priced this into $ions sp projection.

@FormalyTwilter $ions $rhhby The partnership with Roche on Alzheimer could be this APOE4 target. Likely, will be using $ions more advance CNS tech. x.com/i/grok/share/1…

$BIIB $IONS #Alzheimersgene 研究者たちが Nell2 の産生を減少させたところ、 #APOE4遺伝子 を持つ成体マウスにおいても、ニューロンが正常なサイズと発火パターンに回復した。 これは、#Alzheimers を阻害する薬の開発の可能性を示唆している。 ⬇️

@BiotechAnalysst $sgmo x.com/i/grok/share/5…

William Blair #Gene #Editing report highlighting $SGMO modular integrase (#MINT) platform $SGMO preprint: biorxiv.org/content/10.110…

$ions $biib

$ions fiercepharma.com/pharma/biogen-…